Founded in 2023, LifeShare Innovations drives positive change by supporting the advancement of the research and technologies that help health care practitioners better understand diseases and how to improve outcomes for organ, eye and tissue transplantation. We partner with leaders in our profession to foster collaboration between organ procurement organizations (OPOs) and research facilities to save more lives.
Collaborate with us!
At LifeShare Network, we are dedicated to maximizing rare organ donation opportunities by leveraging the unique experience of our colleagues and continually striving to expand our research capabilities.
If you are a collaborator with an idea or innovation that can help us improve and advance organ donation and transplant, we want to hear from you!
Research Partnership
Thank you for considering LifeShare Network as a research partner. LifeShare strives to work with top-tier research groups across the country. If you are interested in collaborating with LifeShare for your research needs, start here by telling us about your work.
Revalia Bio - Research Exclusive Donation
LifeShare Innovations and Revalia Bio work together to advance biomedical research for individuals with end-stage, malignant lung cancer. With Oklahoma ranking 42 out of 42 nationally for lung cancer survival at 21.2%, and 20% of individuals in the state receiving no follow-up care after a lung cancer diagnosis, there is a critical need for innovative approaches to research and treatment.
As a biotech company, Revalia Bio specializes in biomedical research using human organs rather than animal models. Together, we have established a program known as RED (Research, Education, and Donation). RED provides a unique option for individuals facing terminal illness to contribute to biomedical research using their organs. The collaboration ensures donors understand their gift will not only maximize their legacy but also directly impact the future of cancer care.
AnaBios
AnaBios Corporation (AnaBios) is a San Diego-based preclinical CRO specializing in human-focused translational research, offering ethically-sourced human tissues and cells to evaluate drug safety and efficacy in therapeutic areas of high unmet need such as cardiac disease, pain, lung disease and CNS disorders.
ABS Bio (Analytical Biological Services, Inc.) is a Delaware-based biotechnology company providing high-quality biospecimen, biostorage, and cell culture services to support early-stage drug discovery and diagnostics. Founded in 1990, ABS Bio partners with pharmaceutical and biotech organizations as an extension of their lab—delivering reliable human tissues, biofluids, and large-scale cell culture solutions under ISO 9001 and ISO 20387 certifications. With over three decades of experience and recent growth backed by 3 Boomerang Capital, ABS Bio emphasizes scientific excellence, rigorous quality standards, and timely delivery to help accelerate research and development.
OU Biophotonic
The Biophotonic Imaging Laboratory at Stephenson School of Biomedical Engineering (at University of Oklahoma) develops and applies cutting-edge optical imaging techniques—such as multi-photon microscopy, optical coherence tomography and multi-modal biophotonics—to advance diagnostics, monitor therapies and guide interventions in areas including cancer, neuroscience and regenerative medicine.
Based in Stillwater, Oklahoma, MaxQ Research is a specialized packaging and logistics company that designs and manufactures advanced thermal-controlled shippers for temperature-sensitive biologics and life-science products. Their quality systems are ISO 9001:2015 certified and they offer full in-house testing and validation of their packaging solutions. Their “LifeSafe” system is an organ transport container engineered to provide superior temperature stability, movement/temperature-tracking in real time, and streamlined handling for transplant logistics.
Bradon Nave, LifeShare Network Director of Innovations, and Saravan Kumar, Ph.D. Co-founder & CEO, MaxQ Research